Friday 6 November 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024.

Revenue: +6.93%
EPS: −2.02%
Free cash flow: −36.0%
Total debt: −12.5%

Quarter to September 2026, against a year earlier

63.19 1.00 −1.56%

Follow BMY

Alert me

Market cap: $129.0B
P/E: 14.0×
Fwd P/E: 11.9×
Dividend yield: 3.99%
F-score: 8/9
Altman Z: 2.14
Beneish M: −2.69
Dividend safety: 63/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Bristol Myers Squibb Company (BMY) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Bristol Myers Squibb Company (BMY) trades at a P/B ratio of 5.5×. Over the past ten years it has ranged from 1.5× (March 2020) to 9.6× (February 2018); the current reading is higher than 50% of that period. That is above the Drug Manufacturers General industry median of 5.2× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BMY/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Bristol Myers Squibb Company P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BMY/metrics/pb-ratio">Bristol Myers Squibb Company (BMY) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	5.9×	(15.25%)
FY2024	7.0×	88.96%
FY2023	3.7×	(25.15%)
FY2022	4.9×	28.60%
FY2021	3.8×	4.02%
FY2020	3.7×	74.65%
FY2019	2.1×	(64.77%)
FY2018	6.0×	(29.42%)
FY2017	8.5×	40.09%
FY2016	6.1×	(23.56%)

Period	P/B ratio	Change
Sep 2026	5.4×	3.32%
Jun 2026	5.3×	(14.26%)
Mar 2026	6.1×	3.71%
Dec 2025	5.9×	20.09%
43 more quarters	Free account

Against its own ten years

Low 1.5× High 9.6×

Ten-year median 5.5×

Current reading's percentile 55

Company	P/B ratio
SNY Sanofi compare	1.4×
PFE Pfizer Inc. compare	1.9×
GSK GSK PLC Sponsored ADR compare	4.1×
NVO Novo Nordisk A/S compare	5.2×
BMY Bristol Myers Squibb Company	5.5×
AZN AstraZeneca PLC compare	5.6×
NVS Novartis AG compare	8.2×
GILD Gilead Sciences, Inc. compare	16.1×
AMGN Amgen Inc. compare	21.4×
Drug Manufacturers General industry median	5.2×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Bristol Myers Squibb Company (BMY) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on BMY

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on BMY

Stockrow Weekly